Objective Evaluation of Ocular Surface Lubricants in Two Environments
NCT01375582 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2022-11-22
Summary
This study will evaluate ocular surface lubricants in subjects with dry eye syndrome.
Conditions
- Dry Eye
Interventions
- DRUG
-
B & L Soothe Lubricant Eye Drops
Eye Drop
- DRUG
-
Liposic EDO
Eye Drop
- DRUG
-
OcuFresh Eye Wash
Saline drop
Sponsors & Collaborators
-
Bausch & Lomb Incorporated
collaborator INDUSTRY -
University of Rochester
lead OTHER
Principal Investigators
-
James V Aquavella, MD · University of Rochester
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 30 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2012-06-30
- Completion
- 2012-06-30
Countries
- United States
Study Locations
More Related Trials
-
A Dose Ranging Study to Evaluate Safety and Efficacy of Bromfenac Ophthalmic Solution in Dry Eye Disease
NCT01212471 ·Status: COMPLETED ·Phase: PHASE3
-
Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests
NCT04125134 ·Status: TERMINATED ·Phase: PHASE4
-
PMCF Study to Evaluate Performance and Safety of "Distilled Waters-based Eyedrops" Used to Relieve Dry Eye Symptoms
NCT05825586 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants
NCT05992922 ·Status: TERMINATED ·Phase: PHASE2
-
Platelet Rich Plasma Eye Drops for Treatment of Ocular Surface Disease
NCT04608084 ·Status: UNKNOWN ·Phase: PHASE4
-
A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease
NCT02280473 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease
NCT01459588 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Evaluation of a New Preservative in a Lubricating Eye Drop
NCT01434277 ·Status: COMPLETED ·Phase: NA
-
The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease
NCT05759208 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
NCT07068958 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT02242032 ·Status: COMPLETED ·Phase: PHASE1
-
Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers
NCT00135824 ·Status: COMPLETED ·Phase: PHASE4
-
Study Assessing Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01118754 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluation of Safety and Tolerability of Investigational Ocular Lubricants
NCT05888519 ·Status: COMPLETED ·Phase: NA
-
A Clinical Evaluation of an Investigational Lubricant Eye Gel (FID 115958D)
NCT01294956 ·Status: COMPLETED ·Phase: NA
-
Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye
NCT02326090 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.
NCT06244316 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients
NCT03995355 ·Status: COMPLETED
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Safety and Tolerability of Ocular Lubricants
NCT06571656 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy Study of RX-10045 on the Signs and Symptoms of Dry Eye
NCT00799552 ·Status: COMPLETED ·Phase: PHASE2
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality
NCT00622037 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
NCT05660681 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease
NCT07111013 ·Status: WITHDRAWN ·Phase: PHASE3
-
PMCF Study to Evaluate Performance and Safety of "Hyaluronic Acid (HA)-Based Eyedrops" Used to Relieve Dry Eye Symptoms
NCT05807360 ·Status: COMPLETED ·Phase: NA